NEWS
Microexons constitute new potential therapeutic targets for treating diabetes
Elvan Böke’s research group receives a 2-million-euro European Research Consolidator grant
Study showcases synthetic biology's potential in transforming treatment of human disease
RNA splicing regulation influences transcription of genes inked to type-1 and type-1 diabetes risk
European Innovation Council backs CRG start-up to further efforts in treating leading cause of cancer mortality worldwide
The enzyme’s activity was found to be compromised in human cancer cells
Luciano Di Croce and Isabelle Vernos will identify and validate new therapeutics targets for breast cancer and midline gliomas
Visit aimed to foster collaboration between pharma companies and research centres
Lars Velten and Arnau Sebe Pedros have been recognised by the prestigious organisation
Studying noncoding RNAs opens new avenues to understand human disease